Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion

Br J Haematol. 2010 Feb;148(3):483-4. doi: 10.1111/j.1365-2141.2009.07971.x. Epub 2009 Oct 28.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage*
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 5 / genetics*
  • Drug Administration Schedule
  • Female
  • Humans
  • Lenalidomide
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / drug therapy*
  • Thalidomide / administration & dosage
  • Thalidomide / analogs & derivatives*

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide